← Browse by Condition
Medical Condition
refractory acute lymphoblastic leukemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT04996160 Phase 1
Recruiting
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
Enrollment
22 pts
Location
United States
Sponsor
Tanja Andrea Gruber
NCT07166419 Phase 1
Recruiting
Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia
Enrollment
24 pts
Location
United States
Sponsor
Ohio State University Comprehe...